Guo Line Advisory Pte LTD Novo Nordisk A S Transaction History
Guo Line Advisory Pte LTD
- $982 Billion
- Q3 2024
A detailed history of Guo Line Advisory Pte LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Guo Line Advisory Pte LTD holds 287,600 shares of NVO stock, worth $30.3 Million. This represents 3.49% of its overall portfolio holdings.
Number of Shares
287,600
Previous 287,600
-0.0%
Holding current value
$30.3 Million
Previous $41.1 Billion
16.58%
% of portfolio
3.49%
Previous 4.38%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,953Shares Held
321MCall Options Held
5.16MPut Options Held
4.96M-
Jennison Associates LLC21.2MShares$2.24 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.54 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.49 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.41 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.32 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $238B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...